Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $741.7 million.

  • Tandem Diabetes Care's Total Liabilities rose 300.94% to $741.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $741.7 million, marking a year-over-year increase of 300.94%. This contributed to the annual value of $704.6 million for FY2024, which is 1025.53% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's Total Liabilities stood at $741.7 million, which was up 300.94% from $742.5 million recorded in Q2 2025.
  • Tandem Diabetes Care's 5-year Total Liabilities high stood at $766.9 million for Q1 2025, and its period low was $440.9 million during Q1 2021.
  • Moreover, its 5-year median value for Total Liabilities was $625.7 million (2022), whereas its average is $621.1 million.
  • In the last 5 years, Tandem Diabetes Care's Total Liabilities surged by 22380.15% in 2021 and then rose by 3.37% in 2023.
  • Tandem Diabetes Care's Total Liabilities (Quarter) stood at $472.0 million in 2021, then grew by 29.83% to $612.8 million in 2022, then rose by 4.27% to $639.0 million in 2023, then rose by 10.26% to $704.6 million in 2024, then increased by 5.27% to $741.7 million in 2025.
  • Its last three reported values are $741.7 million in Q3 2025, $742.5 million for Q2 2025, and $766.9 million during Q1 2025.